Abstract
The purpose of this study was to determine and compare the prevalence of glaucoma therapy escalation (GTE) after penetrating keratoplasty (PKP) and Descemet’s stripping automated endothelial keratoplasty (DSAEK) in eyes with a surgical indication of pseudophakic corneal edema. A retrospective review was conducted of the medical records of all patients who underwent PKP or DSAEK to treat pseudophakic corneal edema at a tertiary eye care center from January 1 2003 to December 31, 2006. Eyes that were treated with PKP from January 1, 2003 to December 31, 2004 and with DSAEK from January 1, 2005 to December 31, 2006 were included in the statistical analysis. Inclusion criteria included satisfactory preoperative control of intraocular pressure (IOP) and follow-up of at least 12 months. The main outcome measure was GTE, which was defined as a sustained requirement for escalation of topical medical therapy or the need to provide surgical intervention to maintain a satisfactory postoperative IOP. Among 54 eyes that met the inclusion criteria, GTE occurred in 7 (35.0%) of 20 eyes after PKP and in 14 (41.2%) of 34 eyes after DSAEK (P = 0.78) during a mean follow-up period of 27.6 and 28.6 months, respectively. Surgical escalation occurred in 2 (10.0%) eyes after PKP and 2 (5.9%) eyes after DSAEK (P = 0.62), and was associated with late-onset endothelial graft failure in all four eyes. Glaucoma therapy escalation is relatively common and occurs with comparable frequency in eyes with pseudophakic corneal edema after PKP and DSAEK.
Similar content being viewed by others
References
Greenlee EC, Kwon YH (2008) Graft failure: III. Glaucoma escalation after penetrating keratoplasty. Int Ophthalmol 28:191–2007
Thoft RA, Gordon JM, Dohlman CH (1974) Glaucoma following keratoplasty. Trans Am Acad Ophthalmol Otolaryngol 78:OP352–OP364
Goldberg DB, Schanzlin DJ, Brown SI (1981) Incidence of increased intraocular pressure after keratoplasty. Am J Ophthalmol 92:372–377
Simmons RB, Stern RA, Teekhasaenee C, Kenyon KR (1989) Elevated intraocular pressure following penetrating keratoplasty. Trans Am Ophthalmol Soc 87:79–91
Ayyala RS (2000) Penetrating keratoplasty and glaucoma. Surv Ophthalmol 45:91–105
Franca ET, Arcieri ES, Arcieri R, Rocha FJ (2002) A study of glaucoma after penetrating keratoplasty. Cornea 21:284–288
Chien AM, Schmidt CM, Cohen EJ et al (1993) Glaucoma in the immediate postoperative period after penetrating keratoplasty. Am J Ophthalmol 115:711–714
Becker B, Mills DW (1963) Corticosteroids and intraocular pressure. Arch Ophthalmol 70:500–507
Armaly MF (1967) Inheritance of dexamethasone hypertension and glaucoma. Arch Ophthalmol 77:747–751
Spaeth GL, Rodrigues MM, Weinreb S (1977) Steroid-induced glaucoma: a. persistent elevation of intraocular pressure B. Histopathological aspects. Trans Am Ophthalmol Soc 75:353–381
Olson RJ, Kaufman HE (1977) A mathematical description of causative factors and prevention of elevated intraocular pressure after keratoplasty. Invest Ophthalmol Vis Sci 16:1085–1092
Zimmerman TJ, Krupin T, Grodski W, Waltman SR (1978) The effect of suture depth on outflow facility in penetrating keratoplasty. Arch Ophthalmol 96:505–506
Zimmerman T, Olson R, Waltman S, Kaufman H (1978) Transplant size and elevated intraocular pressure. Postkeratoplasty. Arch Ophthalmol 96:2231–2233
Foulks GN, Perry HD, Dohlman CH (1979) Oversize corneal donor grafts in penetrating keratoplasty. Ophthalmology 86:490–493
Olson RJ (1978) Aphakic keratoplasty. Determining donor tissue size to avoid elevated intraocular pressure. Arch Ophthalmol 96:2274–2276
Bourne WM, Davison JA, O’Fallon WM (1982) The effects of oversize donor buttons on postoperative intraocular pressure and corneal curvature in aphakic penetrating keratoplasty. Ophthalmology 89:242–246
Karesh JW, Nirankari VS (1983) Factors associated with glaucoma after penetrating keratoplasty. Am J Ophthalmol 96:160–164
Kirkness CM, Ficker LA (1992) Risk factors for the development of postkeratoplasty glaucoma. Cornea 11:427–432
Sihota R, Sharma N, Panda A et al (1998) Post-penetrating keratoplasty glaucoma: risk factors, management, and visual outcome. Aust N Z J Ophthalmol 26:305–309
Al-Mohaimeed M, Al-Shahwan S, Al-Torbak A, Wagoner MD (2007) Escalation of glaucoma therapy after penetrating keratoplasty. Ophthalmology 114:2281–2286
Goins KM (2008) Surgical alternatives to penetrating keratoplasty II: endothelial keratoplasty. Int Ophthalmol 28:233–246
Wandling GR, Parikh M, Robinson C et al (2010) Escalation of glaucoma therapy after deep lamellar endothelial keratoplasty. Cornea 29:991–995
Burstein NL (1980) Corneal cytotoxicity of topically applied drugs, vehicles, and preservatives. Surv Ophthalmol 25:15–30
Sherwood MB, Grierson I, Millar L, Hitchings RA (1989) Long-term morphologic effects of anti-glaucoma drugs on the conjunctiva and Tenon’s capsule in glaucomatous patients. Ophthalmology 96:327–335
Baudouin C, Pisella PJ, Fillacier K et al (1999) Ocular surface inflammatory changes induced by topical anti-glaucoma drugs: human and animal studies. Ophthalmology 106:556–563
Conflicts of interest
None of the authors have any financial/conflicting interests to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wandling, G.R., Rauen, M.P., Goins, K.M. et al. Glaucoma therapy escalation in eyes with pseudophakic corneal edema after penetrating keratoplasty and Descemet’s stripping automated endothelial keratoplasty. Int Ophthalmol 32, 9–14 (2012). https://doi.org/10.1007/s10792-011-9512-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-011-9512-2